Outcome of 561 non-metastatic triple negative breast cancer

Transkript

Outcome of 561 non-metastatic triple negative breast cancer

                                    

Benzer belgeler

Adjuvant Radiotherapy for Male Breast Carcinoma

Adjuvant Radiotherapy for Male Breast Carcinoma gene technology. This variant has very little or no ER expression and is HER-2 negative. Most triple-negative breast cancers overlap with basal-like phenotype features when studied by microarray te...

Detaylı

Capecitabine/cisplatin doublet in anthracycline and

Capecitabine/cisplatin doublet in anthracycline and Anthracyclines and taxanes are fundamental agents with proven efficacy in every stage of breast cancer. In receptor-negative and hormone-resistant patients who have received anthracycline and taxan...

Detaylı